Why Indian patients groups are opposing patent requests for blockbuster HIV drug lenacapavir
New Delhi: Patent applications filed in India by a US pharmaceutical giant for an antiretroviral drug—meant to prevent Human Immunodeficiency Virus (HIV) infection—are facing stiff opposition from a number of …
